Application of a proapoptotic peptide to intratumorally spreading cancer therapy

Cancer Research

Volumn 73, Issue 4, 2013, Pages 1352-1361

  Chen, Renwei ^a   Braun, Gary B ^a,b   Luo, Xiuquan ^a,b   Sugahara, Kazuki N ^a,b   Teesalu, Tambet ^a,b   Ruoslahti, Erkki ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; BIT1 CELL DEATH DOMAIN PROTEIN; MITOCHONDRIAL PROTEIN; NEUROPILIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER INHIBITION; CELL DEATH; CONTROLLED STUDY; DRUG PENETRATION; DRUG POTENCY; EMBRYO; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; INTERNALIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ENGINEERING; TUMOR CELL CULTURE; TUMOR CELL DESTRUCTION; TUMOR VOLUME;

ANIMALS; APOPTOSIS; BINDING SITES; CARBOXYLIC ESTER HYDROLASES; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEK293 CELLS; HUMANS; MICE; MICE, NUDE; MITOCHONDRIAL PROTEINS; NEOPLASMS; NEUROPILIN-1; OLIGOPEPTIDES; PEPTIDES; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84874330789     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-1979     Document Type: Article

References (39)

1. Frisch SM, Vuori K, Ruoslahti E, Chan-Hui PY. Control of adhesiondependent cell survival by focal adhesion kinase. J Cell Biol 1996;134: 793-9.
2. Jan Y, Matter M, Pai JT, Chen YL, Pilch J, Komatsu M, et al. A mitochondrial protein, Bit1, mediates apoptosis regulated by integrins and Groucho/TLE corepressors. Cell 2004;116:751-62. (Pubitemid 38326732)
3. Biliran H, Jan Y, Chen R, Pasquale EB, Ruoslahti E. Protein kinaseDis a positive regulator of Bit1 apoptotic function. J Biol Chem 2008;283: 28029-37.
4. Kairouz-Wahbe R, Biliran H, Luo X, Khor I, Wankell M, Besch-Williford C, et al. Anoikis effector Bit1 negatively regulates Erk activity. Proc Natl Acad Sci U S A 2008;105:1528-32. (Pubitemid 351346548)
5. Matsuyama A, Hisaoka M, Iwasaki M, Iwashita M, Hisanaga S, Hashimoto H. TLE1 expression in malignant mesothelioma. Virchows Arch 2010;457:577-83.
6. Sonderegger CK, Vogt PK. Binding of the corepressor TLE1 to Qin enhances Qin-mediated transformation of chicken embryo fibroblasts. Oncogene 2003;22:1749-57. (Pubitemid 36513134)
7. De Pereda JM, Waas WF, Jan Y, Ruoslahti E, Schimmel P, Pascual J. Crystal structure of a human peptidyl-tRNA hydrolase reveals a new fold and suggests basis for a bifunctional activity. J Biol Chem 2004;279:8111-5.
8. Hambley TW, Hait WN. Is anticancer drug development heading in the right direction? Cancer Res 2009;69:1259-62.
9. Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer 2006;6:583-92. (Pubitemid 44140857)
10. Sugahara KN, Teesalu T, Karmali PP, Kotamraju VR, Agemy L, Girard OM, et al. Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell 2009;16:510-20.
11. Teesalu T, Sugahara KN, Kotamraju VR, Ruoslahti E. C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc Natl Acad Sci U S A 2009;106:16157-62.
12. Giustini AJ, Ivkov R, Hoopes PJ. Magnetic nanoparticle biodistribution following intratumoral administration. Nanotechnology 2011;22: 345101.
13. Cheresh DA, Spiro RC. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. J Biol Chem 1987;262:17703-11. (Pubitemid 18032258)
14. Ruoslahti E. Peptides as targeting elements and tissue penetration devices for nanoparticles. Adv Mater 2012;24:3747-56.
15. Chang KL, Higuchi Y, Kawakami S, Yamashita F, Hashida M. Efficient gene transfection by histidine-modified chitosan through enhancement of endosomal escape. Bioconjug Chem 2010;21:1087-95.
16. Hatefi A, Megeed Z, Ghandehari H. Recombinant polymer-protein fusion: a promising approach towards efficient and targeted gene delivery. J Gene Med 2006;8:468-76.
17. Lo SL, Wang S. An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection. Biomaterials 2008;29:2408-14.
18. Stevenson M, Ramos-Perez V, Singh S, Soliman M, Preece JA, Briggs SS, et al. Delivery of siRNA mediated by histidine-containing reducible polycations. J Control Release 2008;130:46-56.
19. Collins-Racie LA, McColgan JM, Grant KL, DiBlasio-Smith EA, McCoy JM, LaVallie ER. Production of recombinant bovine enterokinase catalytic subunit in Escherichia coli using the novel secretory fusion partner DsbA. Biotechnology (N Y) 1995;13:982-7.
20. Kaufmann SH. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 1989;49:5870-8.
21. Schmidt O, Pfanner N, Meisinger C. Mitochondrial protein import: from proteomics to functional mechanisms. Nat Rev Mol Cell Biol 2010;11: 655-67.
22. Rapaport D. Finding the right organelle. Targeting signals in mitochondrial outer-membrane proteins. EMBO Rep 2003;4:948-52. (Pubitemid 37407461)
23. van der Laan M, Hutu DP, Rehling P. On the mechanism of preprotein import by the mitochondrial presequence translocase. Biochim Biophys Acta 2010;1803:732-9.
24. Waizenegger T, Stan T, Neupert W, Rapaport D. Signal-anchor domains of proteins of the outer membrane of mitochondria: structural and functional characteristics. J Biol Chem 2003;278: 42064-71. (Pubitemid 37310472)
25. Zhang X, Chen HM, Jaramillo E, Wang L, D'Mello SR. Histone deacetylase- related protein inhibits AES-mediated neuronal cell death by direct interaction. J Neurosci Res 2008;86:2423-31.
26. Karmali PP, Brunquell C, Tram H, Ireland SK, Ruoslahti E, Biliran H. Metastasis of tumor cells is enhanced by downregulation of Bit1. PLoS ONE 2011;6:e23840.
27. Wadia JS, Dowdy SF. Modulation of cellular function by TAT mediated transduction of full length proteins. Curr Protein Pept Sci 2003; 4:97-104. (Pubitemid 36834009)
28. Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009;4:381-4.
29. Roth L, Agemy L, Kotamraju VR, Braun G, Teesalu T, Sugahara KN, et al. Transtumoral targeting enabled by a novel neuropilin-binding peptide. Oncogene 2012;31:3754-63.
30. Ruoslahti E, Bhatia SN, Sailor MJ. Targeting of drugs and nanoparticles to tumors. J Cell Biol 2010;188:759-68.
31. Sugahara KN, Teesalu T, Karmali PP, Kotamraju VR, Agemy L, Greenwald DR, et al. Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science 2010; 328:1031-5.
32. Broker LE, Kruyt FA, Giaccone G. Cell death independent of caspases: a review. Clin Cancer Res 2005;11:3155-62. (Pubitemid 40627860)
33. Celikoglu F, Celikoglu SI, Goldberg EP. Bronchoscopic intratumoral chemotherapy of lung cancer. Lung Cancer 2008;61:1-12.
34. Elstad NL, Fowers KD. OncoGel (ReGel/paclitaxel) - clinical applications for a novel paclitaxel delivery system. Adv Drug Deliv Rev 2009;61:785-94.
35. Engelhard HH. Gene therapy for brain tumors: the fundamentals. Surg Neurol 2000;54:3-9.
36. Hecht JR, Bedford R, Abbruzzese JL, Lahoti S, Reid TR, Soetikno RM, et al. A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clin Cancer Res 2003;9:555-61. (Pubitemid 36182584)
37. Lawson HC, Sampath P, Bohan E, Park MC, Hussain N, Olivi A, et al. Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience. J Neurooncol 2007;83:61-70. (Pubitemid 46647166)
38. Boucher Y, Brekken C, Netti PA, Baxter LT, Jain RK. Intratumoral infusion of fluid: estimation of hydraulic conductivity and implications for the delivery of therapeutic agents. Br J Cancer 1998;78: 1442-8.
39. Wang CC, Li J, Teo CS, Lee T. The delivery of BCNU to brain tumors. J Control Release 1999;61:21-41. (Pubitemid 29406077)